Latest filing published 03 Feb 2026 for BIO-TECHNE Corp.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew McManus: trading record in brief
Matthew McManus is a declared insider at 2 companies; the most frequent names are BIO-TECHNE Corp and Azenta, Inc. In total, 7 filings cover trades dated from 19 August 2022 to 1 February 2026.
No open-market sale appears; the market trades are 1 purchase worth €497k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants and 3 option exercises.
The newest entry dates from 3 February 2026: a share grant of €89k, in BIO-TECHNE Corp. The latest purchase dates back some time: it was published 1,541 days ago, on 22 August 2022. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew McManus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,621 shares0Common StockSEC:0000914190-26-000009:0
- 2,637 shares0Common StockSEC:0001062993-25-014698:0
- 880 shares@ US$53.60100.0% of flowCommon StockSEC:0001062993-25-014698:1
- 4,620 shares0Common StockSEC:0001062993-25-001660:0
- 8,625 shares@ US$58.15100.0% of flowCOMMONSEC:0001209191-22-047012:0Canonical exit: 17 Nov 2022 (T+90)
5 of 5 declarations
